mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.009 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.009 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.01 |